ProHEALTH Care Associates, LLP Report issue

Academic/Hospital Phase 3 Phase 4

Organization Overview

First Clinical Trial
1997
NCT00003088
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Kristine Zinkgraf | ProHealth Care | ProHealth Care, Inc | ProHealth New York - UnitedHealth Group

Active Ingredients

Drugs in Phase 4 Trials (1)

ly3819253 (1 trial)

Drugs in Phase 3 Trials (3)

cyclophosphamide (cytoxan) (1 trial)

doxorubicin (Doxil) (1 trial)

paclitaxel (taxol) (1 trial)

Drugs in Other Trials (1)

lidocaine (xylocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Breast Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 5